Inhibitors of MET kinase
Grant
US12595245B2
Kind: B2
Apr 07, 2026
Assignee
CELYN THERAPEUTICS, INC.
Inventors
Xiaohu S. Ouyang, Toufike Kanouni, John S. Tyhonas, Jason M. Cox, Robert S. Kania
Abstract
Provided herein are inhibitors of MET receptor tyrosine kinase, pharmaceutical compositions comprising said inhibitory compounds, and methods for using said MET kinase inhibitory compounds for the treatment of disease.
CPC Classifications
C07D 401/12
C07D 215/22
C07D 405/14
C07D 471/04
Filing Date
2023-06-26
Application No.
18341503
Claims
18